Everything else on this site is about what Aurorus has already shown. This page is about what it lets researchers ask next — a set of open problems that have long lacked one thing: a sensitive, reproducible instrument that takes no position on the answer. We keep these questions clearly separate from our validated clinical evidence, and we label how far each one sits from proven ground.
Aurorus does not advocate for any theoretical position. It provides a measurement. What a field does with that measurement is for its researchers to determine.
It's a place where a new instrument might let a hard question be asked more cleanly than before. The honest thing is to say how far each one sits from what we've validated — so no reader mistakes an open problem for a finding.
Every entry below carries a distance-to-evidence reading: how much sits on measured ground today, and how much remains genuinely open. The clinical evidence that supports our cleared use lives elsewhere on this site. Nothing here is offered as a medical claim.
An instrument for fields that never had one.
Research into energy-medicine and intention-based modalities has been held back by a single bottleneck: no sensitive, reproducible, agnostic way to measure a physiological response. Without an instrument, the work stays anecdotal. With one, a practice like acupuncture, breathwork, or a bioenergetic therapy can be studied the way anything else is — pre and post, controlled, on numbers that don't care what anyone believes.
Aurorus takes no view on what these modalities are or aren't. It offers a measurement layer, so that a pre-registered study can produce evidence instead of testimony. The claim here is modest and it is the honest one: we can measure; the field can now test.
Where mind meets measurement.
That mental and emotional states move physiology is not controversial — psychoneuroimmunology has said so for decades. What's been missing is a fast, repeatable read to quantify those shifts outside a lab: how meditation, stress, focused attention, or recovery register across a person's physiological state, tracked over minutes and weeks rather than inferred from self-report.
Aurorus is a candidate instrument for that measurement. The stronger claims some make in this area — that consciousness acts on the body through mechanisms not yet understood — are exactly the kind of open question this belongs under: interesting, unproven, and now testable with real endpoints.
The scan as an identifier — a physiological signature.
If a person's electrophysiological read is stable enough over time and distinct enough between individuals, it becomes something a fingerprint or a face is: a way to recognize who someone is — one that is intrinsic, hard to forge, and captured by the same instrument. That's a genuinely different security primitive, and defense and identity-assurance programs have reason to care.
This one sits closer to measured ground than most frontiers, because it's answerable from data we already hold: test–retest stability within a person, separability between people. It is a desk analysis, not a theory — run it, and the question resolves.
Reading radiation exposure from the body itself.
After a radiological event, the first hard question is triage: who was exposed, and how much? Today that answer depends on lab assays and time neither a mass-casualty scene nor a deep-space mission has. A fingertip read of the body's physiological response to ionizing radiation could, in principle, support rapid dose estimation where no lab exists.
The physics is not exotic — ionizing radiation perturbs exactly the oxidative and electrophysiological processes Aurorus already measures. Whether that perturbation resolves into a reliable dose estimate is the open question, and it needs a dose-response study against known exposures that has not yet been run.
Cellular signaling at the quantum scale.
The most speculative item on this page, and we mark it as such. A growing research literature asks whether some cellular processes — coherence, electron transport, photon interactions — involve quantum-scale effects, and whether those effects carry information the body uses. If any of that proves out, an instrument sensitive to the right signals would matter.
We hold this as a direction to watch, not a foundation we build on. It informs where we point future research; it does not underwrite a single present claim about what Aurorus measures. Naming it honestly — as the furthest thing from validated ground — is the point.
Same physics, different species.
Animals present the assessment problem in its hardest form: the patient can't describe a symptom, blood draws mean sedation, and monitoring a working or research animal over time is costly and stressful. A non-invasive read of physiological state — from a paw pad, an ear, a patch of skin — could, in principle, extend the same measurement Aurorus performs in people to companion, working, and research species.
The physics doesn't care about the species; the electrophysiology is there in any living tissue. What's unproven is everything downstream: the capture site, the species-specific mapping, and the validation each animal population would require. It's a genuine future direction — and today it is exactly that, a direction.
A candidate instrument for the hallmarks of aging.
The cutting edge of aging research is no longer about counting years — it's about reading the hallmarks of aging: cellular senescence, mitochondrial dysfunction, epigenetic drift, chronic inflammation, oxidative burden. The open question is whether these processes can be tracked in a living person, non-invasively, often enough to see interventions land. Blood-based clocks and molecular assays cover part of the ground; what's still missing is a longitudinal physiological read that moves at the speed of the biology.
Aurorus's signal sits on that same substrate — oxidative activity, autonomic function, cellular energetics. Whether the read correlates with established aging biomarkers, whether it shifts in response to senolytics or other interventions, whether it can be validated as an objective marker of biological age: these are the open questions this frontier maps. The mechanism is plausible; the aging-biomarker validation study has not been done.
The frontier questions above are no longer confined to the fringe. Major academic centers have started running controlled studies on bioenergetic and biofield-related effects with rigorous methodology — a signal that the category is becoming a legitimate object of study rather than a taboo one.
We cite this kind of work for one reason only: to show the questions are being taken seriously by serious people. We do not present it as evidence for Aurorus, and it does not concern our instrument — much of it studies therapies, not measurement. It sets context, nothing more.
e.g. Yang & Cohen et al., preclinical biofield-therapy study in pancreatic cancer, Cancer Medicine (2026), MD Anderson.
Cited as evidence the category is taken seriously — not as validation of Aurorus, and not a measurement study.
If your work lives at one of these frontiers — or somewhere we haven't mapped — we support research partnerships, pre-registered studies, and instrument access. Tell us what you're trying to measure.
Routed to our research team · not a sales inquiry.
The research directions described on this page are open scientific questions, not cleared capabilities or medical claims. Aurorus is FDA De Novo cleared (DEN150004) as an electrophysiological measurement tool for general wellness and research use. It is not intended to diagnose, treat, cure, or prevent any disease. Frontier research described here is exploratory; nothing on this page has been cleared for any diagnostic use, and several directions are explicitly speculative. Third-party studies cited for context do not concern Aurorus and are not evidence of its performance. Results should be interpreted by qualified professionals.